Oragenics Inc SEC filings OGEN
Oragenics Inc has 1,003 filings in SEC EDGAR's recent list, going back to Jun 20, 2007. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 16, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3/A | Filing | Mar 19, 2026 | — |
| S-3 | Shelf registration | Jan 22, 2026 | — |
| S-8 | Employee stock plan registration | Aug 26, 2025 | — |
| 424B5 | Prospectus supplement | Jul 2, 2025 | — |
| S-1/A | Amended registration statement | Jun 30, 2025 | — |
| S-1 | Registration statement | Jun 23, 2025 | — |
| S-1/A | Amended registration statement | Jan 8, 2025 | — |
| S-1/A | Amended registration statement | Dec 31, 2024 | — |
| S-1 | Registration statement | Dec 18, 2024 | — |
| S-8 | Employee stock plan registration | Dec 16, 2024 | — |
| 424B5 | Prospectus supplement | Oct 11, 2024 | — |
| 424B5 | Prospectus supplement | Sep 5, 2024 | — |
| S-1/A | Amended registration statement | Sep 3, 2024 | — |
| S-1 | Registration statement | Aug 16, 2024 | — |
| 424B5 | Prospectus supplement | Jun 25, 2024 | — |
| 424B5 | Prospectus supplement | Jun 25, 2024 | — |
| 424B5 | Prospectus supplement | Feb 29, 2024 | — |
| FWP | Free writing prospectus | Feb 27, 2024 | — |
| 424B5 | Prospectus supplement | Feb 27, 2024 | — |
| FWP | Free writing prospectus | Jan 16, 2024 | — |
| 424B5 | Prospectus supplement | Jan 16, 2024 | — |
| S-8 | Employee stock plan registration | Jan 10, 2024 | — |
| 424B5 | Prospectus supplement | Feb 24, 2023 | — |
| S-3 | Shelf registration | Jan 13, 2023 | — |
| 424B5 | Prospectus supplement | Apr 20, 2022 | — |
| S-8 | Employee stock plan registration | Mar 24, 2022 | — |
| 424B5 | Prospectus supplement | Mar 5, 2021 | — |
| 424B5 | Prospectus supplement | Feb 1, 2021 | — |
| 424B5 | Prospectus supplement | Dec 28, 2020 | — |
| 424B5 | Prospectus supplement | Nov 20, 2020 | — |
| 424B5 | Prospectus supplement | Nov 19, 2020 | — |
| 424B3 | Prospectus | Jun 30, 2020 | — |
| S-3 | Shelf registration | May 29, 2020 | — |
| S-3 | Shelf registration | Dec 31, 2019 | — |
| S-8 | Employee stock plan registration | Jun 24, 2019 | — |
| 424B5 | Prospectus supplement | Mar 22, 2019 | — |
| S-3MEF | Filing | Mar 20, 2019 | — |
| 424B5 | Prospectus supplement | Mar 20, 2019 | — |
| 424B4 | Prospectus | Jul 13, 2018 | — |
| S-1MEF | Filing | Jul 12, 2018 | — |
| S-1/A | Amended registration statement | Jul 11, 2018 | — |
| S-1/A | Amended registration statement | Jul 9, 2018 | — |
| FWP | Free writing prospectus | Jul 5, 2018 | — |
| S-1/A | Amended registration statement | Jul 5, 2018 | — |
| S-8 | Employee stock plan registration | Jun 26, 2018 | — |
| S-1 | Registration statement | May 15, 2018 | — |
| 424B3 | Prospectus | May 8, 2018 | — |
| S-1 | Registration statement | Apr 27, 2018 | — |
| 424B5 | Prospectus supplement | Apr 10, 2018 | — |
| S-8 | Employee stock plan registration | Feb 16, 2018 | — |
| S-3/A | Amendment no. 1 to form s-3 | Sep 1, 2016 | — |
| S-3 | Shelf registration | Aug 25, 2016 | — |
| 424B5 | Prospectus supplement | Nov 15, 2013 | — |
| 424B5 | Prospectus supplement | Nov 15, 2013 | — |
| S-3 | Shelf registration | Aug 14, 2013 | — |
| 424B3 | Prospectus | May 3, 2013 | — |
| POS AM | Post effective amendment no 1 to form s-1 on form s-3 | Apr 23, 2013 | — |
| 424B3 | Prospectus | Apr 8, 2013 | — |
| 424B3 | Prospectus | Feb 15, 2013 | — |
| 424B3 | Prospectus | Dec 19, 2012 | — |
| 424B3 | Prospectus | Nov 14, 2012 | — |
| S-8 | Employee stock plan registration | Oct 25, 2012 | — |
| 424B3 | Prospectus | Oct 25, 2012 | — |
| 424B3 | Prospectus | Sep 27, 2012 | — |
| S-1/A | Amended registration statement | Sep 21, 2012 | — |
| S-1 | Registration statement | Aug 31, 2012 | — |
| S-8 | Employee stock plan registration | Sep 30, 2011 | — |
| S-1/A | Amended registration statement | Oct 5, 2010 | — |
| S-1 | Registration statement | Aug 25, 2010 | — |
| POS AM | Filing | Apr 13, 2010 | — |
| POS AM | Filing | Apr 13, 2010 | — |
| POS AM | Filing | Apr 13, 2010 | — |
| POS AM | Filing | Apr 13, 2010 | — |
| POS AM | Filing | Nov 13, 2009 | — |
| S-8 | Employee stock plan registration | Nov 13, 2009 | — |
| S-8 | Employee stock plan registration | May 7, 2008 | — |
| 424B3 | Prospectus | Nov 14, 2007 | — |
| 424B3 | Prospectus | Sep 27, 2007 | — |
| S-3 | Shelf registration | Sep 14, 2007 | — |
| 424B3 | Prospectus | Aug 20, 2007 | — |
| 424B3 | Prospectus | Jul 5, 2007 | — |
| POS AM | Post effective amendment no. 3 to form sb-2 | Jun 20, 2007 | — |
Showing 82 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OGEN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Lakewood Ranch, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1174940
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.